CCL3 and hepatocellular carcinoma: The enhancement of IL-37 expression by HCC cells is accompanied by an increase in the levels of CCL3 (chemokine (C-C motif) ligand 3) and CCL20, which further promotes the recruitment of CD1a+ dendritic cells (DCs) in the tumor infiltrate [20].